K162891

Substantially Equivalent

Complete Control System

Applicant: Coapt, LLC
Product code: GXY
Advisory panel: Neurology
Date received: 2016-10-17
Decision date: 2017-04-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chicago, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.